Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

June 28, 2023

Amanda Delle Donne Named Associate After Admission to New York State Bar

Barclay Damon announces Amanda Delle Donne has been admitted to the New York State Bar. Delle Donne, a former law clerk at Barclay Damon, is now an associate at the firm. 

Delle Donne is a member of the Trusts & Estates and Corporate Practice Areas. She graduated from the University at Buffalo School of Law, where she was editor-in-chief of the Buffalo Human Rights Law Review and an associate on the Buffalo Environmental Law Journal. Her experience includes serving as a law clerk at Barclay Damon; Friedman & Ranzenhofer, PC; Cole, Sorrentino, Hurley, Hewner and Gambino, PC; and the Center for Elder Law & Justice. She also served as a judicial extern for the Honorable Acea M. Mosey in the Erie County Surrogate’s Court and as a legal intern at the Law Offices of Leonard A. Rosner. Delle Donne is based in the firm’s Rochester office.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients’ businesses. With nearly 300 attorneys, Barclay Damon is a leading law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto. For more information, visit our award-winning website at barclaydamon.com.
 

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks